UB Paderborn / Katalog / Suche / in CDI

1 – 14 von 14

Sortiert nach

Expression of Wilms' tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants

Annals of hematology, 2004-12, Vol.83 (12), p.745-750

2004

Volltextzugriff (PDF)

Wilms tumor gene (WT1) expression as a panleukemic marker

International journal of hematology, 2002-08, Vol.76 (2), p.103-109

2002

Volltextzugriff (PDF)

Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma : Results of a phase II study

Cancer, 2005-08, Vol.104 (3), p.611-617

2005

Volltextzugriff (PDF)

Possible regulation of Wilms’ tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA‐1 in human acute myeloid leukaemias

British journal of haematology, 2003-10, Vol.123 (2), p.235-242

2003

Volltextzugriff (PDF)

A two-cohort phase II clinical trial of gemcitabine plus treosulfan in patients with metastatic uveal melanoma

Melanoma research, 2005-10, Vol.15 (5), p.447-451

2005

Volltextzugriff (PDF)

Lymphoma-associated mortality in the German HIV-lymphoma cohort study

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.7550-7550

2016

Volltextzugriff (PDF)

Survival of patients with different AIDS-related lymphoma subtypes

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.8548-8548

2014

Volltextzugriff (PDF)

Quantitative Analysis of Wilms' Tumor Gene 1(WT1) Expression in Acute Lymphoblastic Leukemia (ALL) of Adults Reveals Lower WT1 Levels Than in Acute Myeloid Leukemias (AML) and Varying Expression Levels between Individual Patients among Different ALL Subgroups

Blood, 2005-11, Vol.106 (11), p.4545-4545

2005

Volltextzugriff (PDF)

Ifosfamide/liposomal daunorubicin is a well tolerated and active first‐line chemotherapy regimen in advanced soft tissue sarcoma

Cancer, 2005-08, Vol.104 (3), p.611-617

2005

Volltextzugriff (PDF)

Treatment of AIDS-related lymphomas: rituximab is beneficial even in severely immunosuppressed patients

AIDS (London), 2012-02, Vol.26 (4), p.457-464

2012

Volltextzugriff (PDF)

Phase II Trial of Carboplatin, Paclitaxel Plus Vinorelbine in Non-small Cell Lung Cancer Patients

Anticancer research, 2005-03, Vol.25 (2B), p.1333-1336

2005

Volltextzugriff (PDF)

A clinical phase I trial of gemcitabine and treosulfan in uveal melanoma and other solid tumours

European journal of cancer (1990), 2004-09, Vol.40 (14), p.2047-2052

2004

Volltextzugriff (PDF)

Platelet Glycoprotein Expression in Patients with Myelodysplastic Syndrome

Thrombosis research, 2000-10, Vol.100 (1), p.27-34

2000

Volltextzugriff (PDF)

1 – 14 von 14

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(14)

Sprache

Englisch
(14)
Japanisch
(2)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Expression of Wilms' tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants

Wilms tumor gene (WT1) expression as a panleukemic marker

Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma : Results of a phase II study

Possible regulation of Wilms’ tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA‐1 in human acute myeloid leukaemias

A two-cohort phase II clinical trial of gemcitabine plus treosulfan in patients with metastatic uveal melanoma

Lymphoma-associated mortality in the German HIV-lymphoma cohort study

Survival of patients with different AIDS-related lymphoma subtypes

Quantitative Analysis of Wilms' Tumor Gene 1(WT1) Expression in Acute Lymphoblastic Leukemia (ALL) of Adults Reveals Lower WT1 Levels Than in Acute Myeloid Leukemias (AML) and Varying Expression Levels between Individual Patients among Different ALL Subgroups

Ifosfamide/liposomal daunorubicin is a well tolerated and active first‐line chemotherapy regimen in advanced soft tissue sarcoma

A stable and replicable neural signature of lifespan adversity in the adult brain

Treatment of AIDS-related lymphomas: rituximab is beneficial even in severely immunosuppressed patients

Phase II Trial of Carboplatin, Paclitaxel Plus Vinorelbine in Non-small Cell Lung Cancer Patients

A clinical phase I trial of gemcitabine and treosulfan in uveal melanoma and other solid tumours

Platelet Glycoprotein Expression in Patients with Myelodysplastic Syndrome

Suchergebnisse filtern